article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure. All rights reserved.

article thumbnail

Declining Uveitic Glaucoma Incidence and Subtype Risks

Physician's Weekly

The following is a summary of “Incidence and Prevalence of Glaucoma, Corticosteroid Response, and Ocular Hypertension in Uveitis and its Anatomical Subtypes,” published in the June 2025 issue of American Journal of Ophthalmology by Marshall et al. The highest rates of ocular hypertension (n=465; 17.9%, 95% CI 16.4-19.3%)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Maria Ansari, MD, FACC, named to Modern Healthcare’s list of 50 Most Influential Clinical Executives

Permanente Medicine

June 10, 2025) — Maria Ansari, MD, FACC , co-CEO of The Permanente Federation at Kaiser Permanente, has been named to Modern Healthcare’s list of 50 Most Influential Clinical Executives for 2025. The result is high-quality, high-value care within an integrated system — improving lives and shaping the future of health care.”

Clinic 59
article thumbnail

Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.

Physician's Weekly

The number of patients with heart failure is expected to rise sharply owing to ageing populations, poor dietary habits, unhealthy lifestyles and improved survival rates from conditions such as hypertension and myocardial infarction. Springer Nature Limited. first appeared on Physician's Weekly.

article thumbnail

Molecular Analysis Improves FH Prognosis & Risk Stratification

Physician's Weekly

Luis Rodríguez-Padial, MD, PhD , and colleagues assessed patients found via a population-based diagnostic screening for FH that included a genetic analysis to improve “our understanding of the phenotype/genotype relationships associated with FH that can help optimize treatments and thereby improve prognoses.”

article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

Medical societies and hospitals are weighing in on periprocedural concerns in patients taking GLP-1s who need procedures or surgeries. That’s according to two internists who work closely with hospitalized patients who take GLP-1s. These medications are truly life-changing for many patients.”

article thumbnail

Caring for the Unrepresented: A Podcast with Joe Dixon, Timothy Farrell, Yael Zweig

GeriPal

So I think the first reason that we saw and felt the opportunity was ripe for updating was that some of us had come across some anecdotal examples of patients expressing some offense to that terminology. And I was asking this patient about if he had filled out an advanced directive. Is the patient in your descriptor?